Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases

PURPOSE: Anti-phospholipid antibodies (aPL) analyzed by line immunoassay (LIA) can recognize beta(2)-glycoprotein I (β(2)GPI) domain 1 (D1) epitopes depending on β(2)GPI binding to distinct phospholipids. The aPL LIA was compared with consensus ELISA to investigate whether both techniques can discri...

Descripción completa

Detalles Bibliográficos
Autores principales: Nalli, Cecilia, Somma, Valentina, Andreoli, Laura, Büttner, Thomas, Schierack, Peter, Mahler, Michael, Roggenbuck, Dirk, Tincani, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975024/
https://www.ncbi.nlm.nih.gov/pubmed/29845583
http://dx.doi.org/10.1007/s13317-018-0106-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975024/
https://www.ncbi.nlm.nih.gov/pubmed/29845583
http://dx.doi.org/10.1007/s13317-018-0106-0

Ejemplares similares